Mobile

A Multicenter, Multinational, Open-Label Study of the Effects of Aldurazyme(laronidase) Treatment on Lactation in Women with Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-007003-33

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

1. To determine whether Aldurazyme affects lactation in women with MPS I. 2. To determine whether α-L-iduronidase is present in the breast milk of mothers with MPS I who are being treated with Aldurazyme. 3. To determine whether Aldurazyme affects the growth, development, and immunologic response of breastfed infants born to mothers with MPS I who are being treated with Aldurazyme.

Critère d'inclusion

  • mucocopolysaccharidoses I

Liens